ethosuximide has been researched along with Lennox Gastaut Syndrome in 2 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Lennox Gastaut Syndrome: A childhood-onset epilepsy syndrome.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hoshino, H | 1 |
Miya, F | 1 |
Kato, M | 1 |
Kanemura, H | 1 |
Brigo, F | 1 |
Striano, P | 1 |
Belcastro, V | 1 |
1 review available for ethosuximide and Lennox Gastaut Syndrome
Article | Year |
---|---|
A reappraisal of atypical absence seizures in children and adults: therapeutic implications.
Topics: Anticonvulsants; Epilepsy, Generalized; Ethosuximide; Humans; Lamotrigine; Lennox Gastaut Syndrome; | 2019 |
1 other study available for ethosuximide and Lennox Gastaut Syndrome
Article | Year |
---|---|
Efficacy of ethosuximide on atonic seizures with KCNB1 mutation.
Topics: Anticonvulsants; Child; Electroencephalography; Ethosuximide; Humans; Lennox Gastaut Syndrome; Male; | 2022 |